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Human Neonatal Fc Receptor Mediates Transport
of IgG into Luminal Secretions for Delivery
of Antigens to Mucosal Dendritic Cells
approximately 300 g/ml in nasal secretions (Hanson
and Brandzaeg, 1980) to 800 g/ml in the human rectum
(Kozlowski et al., 1997). Recent reports have also shown
that passive administration of neutralizing IgGs can pre-
vent mucosal human immunodeficiency virus transmis-
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sion in rhesus macaques or macaque neonates (Robert-Department of Medicine
Guroff, 2000). Together, these observations support theBrigham and Women’s Hospital
concept that IgG along the mucosal surfaces can serveBoston, Massachusettes 02115
an important role in mucosal protection. However, the2 Department of Pathology
mechanisms(s) by which IgG gains access to the lumenMassachusetts General Hospital
and the biological functions of IgG once present in thisBoston, Massachusetts 02114
location remain undefined.3 The Jackson Laboratory
Recent evidence has pointed toward a role for the600 Main Street
neonatal Fc receptor (FcRn) in these processes. FcRnBar Harbor, Maine 04609
is structurally related to MHC class I molecules and4Gastrointestinal Cell Biology
consists of a heterodimer composed of a glycosylatedDepartment of Medicine
heavy () chain in noncovalent association with 2-Children’s Hospital
microgloblin (2m) (Gastinel et al., 1992; Simister andBoston, Massachusetts 02115
Mostov, 1989). This molecule was originally identified in5 The Harvard Digestive Diseases Center
the intestinal epithelium of suckling rats as the receptorBoston, Massachusetts 02115
responsible for the well-known transport of maternal
IgG across the intestinal epithelium into the bloodstream
(Abrahamson and Rodewald, 1981; Brambell, 1966;Summary
Jones and Waldmann, 1971). This ability to move IgG
in an apical to basolateral direction across the intestinalMucosal secretions of the human gastrointestinal, re-
epithelium is a major distinguishing cell biologic featurespiratory, and genital tracts contain significant quanti-
of FcRn in comparison to the pIgR. Although FcRn wasties of IgG. The mechanism by which IgG reaches lumi-
originally described as being developmentally regulatednal secretions and the function of IgG in these
in rodent intestine in that its functional expression atlocations are unknown. Here, we find that the human
birth was notably downregulated approximately 1000-neonatal Fc receptor (FcRn) is the vehicle that trans-
fold at the time of weaning (Ghetie et al., 1996), it hasports IgG across the intestinal epithelial barrier into
recently become apparent that FcRn continues to bethe lumen where the IgG can bind cognate antigen.
detectable at significant levels in many adult cell typesThe FcRn can then recycle the IgG/antigen complex
in both rodents and humans (Blumberg et al., 1995;back across the intestinal barrier into the lamina pro-
Dickinson et al., 1999; Israel et al., 1997; Leach et al.,pria for processing by dendritic cells and presentation
1996; Spiekermann et al., 2002; Zhu et al., 2001). Into CD4 T cells in regional organized lymphoid struc-
in vitro cell models that express FcRn and that alsotures. These results explain how IgG is secreted onto
exhibit cellular polarity, FcRn-mediated IgG transportmucosal surfaces and scavenges luminal antigens for
exhibits bidirectionality predicting that adult expressionrecognition by the immune system.
of FcRn may endow upon polarized epithelia the ability
to move FcRn-bound cargo from either the lumen or
Introduction
tissue spaces into the opposite pole of the cell with
a steady-state distribution of transport in vivo that is
Humoral immunity as mediated by secretory (s)IgA and directed abluminally into the tissue (Claypool et al., 2002;
IgG plays an important role in mucosal tissues as a Dickinson et al., 1999; McCarthy et al., 2000; Praetor et
first line of defense against microorganisms. Within the al., 1999). In this context, it is of interest that FcRn has
gastrointestinal and genitourinary tracts and lung, ac- been not only functionally linked to the passive acquisi-
cess of immunoglobulins to mucosal secretions must tion of immunity in neonatal rodents through the trans-
occur in the context of a barrier imposed by epithelial port of maternal IgG but also to IgG-mediated immune
cells that separates the host from the external environ- surveillance based upon the indirect morphologic ob-
ment (Madara, 1998). sIgA is transported across epithe- servation made more than two decades ago that FcRn
lial cells from tissue spaces into the lumen through an is also capable of transporting antigen-antibody com-
active unidirectional process involving the polymeric Ig plexes across the intestinal epithelium from the lumen
receptor pIgR (Johansen et al., 1999). IgG can also be during neonatal rodent life (Abrahamson et al., 1979).
detected within the intestinal lumen of the adult human This raises the hypothesis that a major function of FcRn
that, in certain tissue locations, may reach levels approx- in adult human life is to transport IgG into the apical
imating that observed for sIgA. In fact, the levels of IgG region of the epithelium for retrieval of antigens, where-
reached in fluids can be quite significant ranging from upon FcRn can scavenge these complexes for transport
back into the lamina propria. Such a pathway could
significantly contribute to the regulation of immune re-*Correspondence: rblumberg@partners.org
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Figure 1. Specific Binding of Rabbit IgG to hFcRn
Mock-MDCK and hFcRn/h2m-MDCK were lysed in CHAPS buffer (pH 6.0 or 8.0), and each lysate preincubated with IgGs was incubated
with protein G-Sepharose. Bound proteins were analyzed by SDS-PAGE under nonreducing conditions and immunoblotted for the HA tag
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sponses by providing a mechanism for luminal anti- Antibody/Antigen Complexes Can Be
Transported across Polarized MDCK Cellsgen(s) to gain access to professional antigen-presenting
cells, such as dendritic cells, which are known to be in an FcRn-Dependent Pathway
We next determined whether hFcRn contributes to theboth present at this location and capable of interacting
with CD4 T cells. Through an examination of in vitro transport of immune complexes across an epithelial bar-
rier. Goat anti-hIgG F(ab)2 or goat anti-mIgG F(ab)2 act-and in vivo model systems, this report provides direct
evidence in support of this hypothesis. ing as model antigens due to their lack of Fc regions
were applied to the apical reservoir, and hIgG was also
applied to the basolateral reservoir. Strong uptake ofResults
goat anti-hIgG F(ab)2 was detectable when goat anti-
hIgG F(ab)2 was applied to the apical surface and hIgGTransport of Human and Rabbit IgG across Polarized
was applied to the basolateral surface of hFcRn/h2m-MDCK Cells Expressing hFcRn and h2m
MDCK cells (Figure 1J) but not mock-MDCK cells (FigureFcRn has been recently demonstrated to be capable of
1L). In contrast, when goat anti-mIgG F(ab)2 was appliedtransporting IgG bidirectionally across epithelial barri-
to the apical chamber or when goat anti-hIgG F(ab)2ers. Given the likelihood that luminal- or epithelial-asso-
was applied apically without application of hIgG basolat-ciated IgG would be expected to interact with local anti-
erally, no green signal was detectable (Figures 1H andgens of the appropriate specificity, we predicted that
1I). Consistent with the work of others (Claypool et al.,FcRn is capable of retrieving luminal antigen/IgG com-
2004; Praetor et al., 1999), buffering the input chamberplexes for transport back into the lamina propria. In an
of the apical reservoir to pH 6.0 significantly enhancedinitial series of studies we determined whether hIgG
the ability to detect the goat anti-hIgG intracellularlyand rabbit anti-OVA IgG could be recognized by hFcRn
within the hFcRn/h2m-MDCK cells in the presence ofexpressed in the transfected MDCK cell line. Both hIgG,
basolaterally applied hIgG (Figures 1J and 1K). Also con-rabbit control IgG, and rabbit anti-OVA IgG but not
sistent with previous observations (Claypool et al.,mouse IgG1 were capable of associating with and pull-
2004), buffering the basolateral chamber to pH 6.0 wasing down hFcRn as a complex with h2m at pH 6.0 but
not necessary to observe apically directed transcytosisnot at pH 8.0 (Figures 1A–1C), consistent with previous
from the basolateral chamber. These preliminary studiesstudies, which have demonstrated that hFcRn can bind
show that hFcRn can mediate the transport of IgG fromto rabbit IgG but not mouse IgG1 (Ober et al., 2001). The
the basolateral to apical compartment for retrieval ofexistence of two FcRn bands was consistently observed
antigens as an immune complex.and represents hFcRn containing mature (upper band
To test whether such an immune complex can bein Figure 1A) and immature (lower band in Figure 1A)
transcytosed, we prepared immune complexes by incu-carbohydrate side chain modifications as previously de-
bating rabbit anti-OVA IgG or nonspecific rabbit IgG andscribed (Claypool et al., 2002).
biotin-conjugated OVA (B-OVA) for 30 min and appliedWe next examined whether hIgG and rabbit IgG are
these to the apical reservoir of a transwell system. Astransported across a polarized monolayer in an FcRn-
expected, rabbit IgG could be detected in the hFcRn/dependent manner. To do so, hIgG or rabbit anti-OVA
h2m MDCK cells exposed to control IgG and anti-OVAIgG was applied to either the apical or basolateral reser-
IgG (Figure 2A). Although small quantities of B-OVA asvoir. By this method, both hIgG and rabbit anti-OVA IgG
a baseline signal could be detected in either the absencecould be shown to be bidirectionally transported by two
of any rabbit IgG (data not shown) or the presence ofdifferent hFcRn/h2m-MDCK (#14 and #45) but not
control rabbit IgG in both MDCK cells (Figure 2B), onlymock-MDCK cell lines (Figures 1D and 1E). Further dem-
in the presence of both specific anti-OVA IgG and theonstrating the receptor-mediated origin of this transport,
hFcRn/h2m-MDCK cell line could high-level transportrabbit control IgG (Figure 1F) or hIgG (data not shown)
of B-OVA (Figure 2B) and OVA/anti-OVA IgG immunedose dependently suppressed the transport of the rabbit
complexes (Figure 2C) be detected. Similar observa-anti-OVA IgG. In contrast, chicken IgY (2.5 mg/ml), which
tions were made when immune complex transport wasis unable to bind hFcRn (Claypool et al., 2002; Dickinson
assessed in the basolateral to apical direction consis-et al., 1999), failed to abolish this transport (data not
tent with the bidirectionality of this transport processshown). These observations confirm that, like hIgG, rab-
bit IgG can bind and be transcytosed by hFcRn. as previously shown for IgG antibodies (data not shown
(A), h2m (B), and hFcRn-CT (C). (C) Whole-cell lysate (WCL) of the hFcRn/h2m-MDCK cells. Bidirectional transcytosis of human and rabbit
IgG by hFcRn in MDCK cell lines expressing hFcRn/h2m. (D–F) Human IgG (100 g/ml) or rabbit IgG (anti-OVA IgG; 100 g/ml) was added
to either apical or basolateral reservoir on transwell filters of mock-MDCK (open bars) and hFcRn/h2m-MDCK (#14 and #45; closed bars)
and cultured for 90 min. The output solution was collected from the opposite reservoir and subjected to ELISA for measuring the concentrations
of hIgG (D) and rabbit IgG (E). (F) To further demonstrate receptor-mediated transport, rabbit control IgG at a final concentration of 100 g/ml
or 1000 g/ml was added to the apical reservoir with 100 g/ml anti-OVA IgG. After 90 min incubation, the output solution was collected and
the concentration of rabbit anti-OVA IgG was assessed. The bars represent the mean  SD. *p  0.05 and **p  0.01. Enhanced goat anti-
hIgG was internalized from the apical membrane when hIgG was added in the basolateral reservoir in hFcRn/h2m-MDCK cells. Either goat
anti-hIgG F(ab)2 (40 g/ml) or goat anti-mIgG F(ab)2 (40 g/ml) buffered at pH 6.0 (G–J and L) or pH 7.4 (K) was internalized from the apical
chambers and hIgG (40 g/ml) buffered at pH 7.4 was (I–L) or was not (G and H) added to the basolateral reservoir of filter-grown hFcRn/
h2m-MDCK cells (G–K) and control MDCK cells (L) for 2 hr. The cells were fixed, permeabilized, and stained with anti-goat IgG (green) and
ZO-1 (red) and the photos prepared at the level of tight junction (ZO-1). The schemas above each photo represent the condition of the apical
and basolateral reservoirs. Scale bars, 5 microns.
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Figure 2. Transcytosis of Antigen/IgG Complexes by FcRn in MDCK Cell Lines Expressing hFcRn/h2m
Mock-MDCK (open bars) and hFcRn/h2m-MDCK (closed bars) cells were grown on transwell filters until confluent. (A–C) B-OVA (33 g/ml)/
control IgG (100 g/ml) or B-OVA/anti-OVA IgG was added to the apical reservoir. After 90 min incubation, the supernatant obtained from the
basolateral reservoir was subjected to ELISA. (D) B-OVA was added to the apical reservoir (100 ng/ml) and either control IgG or anti-OVA IgG
was added to the basolateral reservoir (100 g/ml). After 180 min incubation, the bottom reservoirs were washed with cold PBS and incubated
with fresh HBSS containing 1% BSA (pH 7.4). After an additional 180 min incubation, the supernatant obtained from the bottom reservoir was
subjected to ELISA. The bars represent the mean  SD (*p  0.05, **p  0.01). (E and F) Detection of B-OVA/anti-OVA IgG complex by
immunoblot. An equal quantitity (100 ng) as determined by B-OVA ELISA was obtained from the basolateral reservoir of a transwell system
that had been incubated apically with B-OVA/anti-OVA IgG or B-OVA/control IgG. As controls for immunoblot, B-OVA with rabbit control IgG
and B-OVA with rabbit anti-OVA IgG were also used. The supernatants were incubated with avidin-agarose beads and the bound proteins
subjected to immunoblot analysis using mouse anti-OVA antibodies followed by HRP-conjugated anti-mouse IgG1 (E) or HRP-conjugated
donkey anti-rabbit IgG antibodies (F). The arrow in (E) indicates the molecular weight of OVA and the arrow in (F) indicates that of the IgG
heavy chain. The samples are as follows: lane 1, B-OVA (100 ng/well) with rabbit control IgG (30 ng/well); lane 2, B-OVA (100 ng/well) with
rabbit anti-OVA IgG (30 ng/well); lane 3 and 6, mock-MDCK cells; lanes 4, 5, 7, and 8, two different hFcRn/h2m-MDCK clones.
and Figures 1D and 1E). These results indicate that IgG was applied to the basolateral reservoir. Only in the
presence of both specific anti-OVA IgG and the hFcRn/hFcRn can transport an immune complex.
Next, to assess whether IgG transported in a basolat- h2m-MDCK cell line could significant transport of
B-OVA as a complex be detected (Figure 2D). Theseeral to apical direction could retrieve antigens from the
apical reservoir for transport as an immune complex results indicate that the observed transport of immune
complexes across an intact epithelial barrier describedback into the basolateral reservoir, B-OVA was applied
to the apical reservoir and either anti-OVA IgG or control above is likely to be physiologic given the ability of
Transcytosis of IgG/Antigen Complexes by FcRn
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hFcRn to mediate the retrieval of free antigen from the OVA IgG but not control IgG IL-2, production was in-
creased, (Figure 3B) but not with medium from mock-apical luminal milieau when antigen-specific IgG is pres-
ent basolaterally as modeled in the transfected MDCK MDCK cells treated with OVA/anti-OVA IgG. To confirm
the physiologic nature of the antigen presentation ob-cells.
We also directly tested whether B-OVA/IgG com- served, the naive CD4 T cells from DO11.10 mice were
also cultured for 60 hr. The OVA-specific CD4 T cellsplexes can be detected by immunoblot to show the fact
that intact OVA could be transported by FcRn-express- were only stimulated, as indicated by the production of
IFN- (Figure 3C) and IL-10 (Figure 3D), when cellsing epithelial cells. To do so, B-OVA and B-OVA/IgG
complexes were retrieved from the basolateral reservoir pulsed with the basolateral medium from hFcRn/h2m-
MDCK cells incubated with OVA/anti-OVA IgG.by concentration with avidin-agarose. When OVA was
transported apical to basal across the hFcRn/h2m- These results indicate that OVA transported across
polarized epithelial cells in the apical to basolateral di-MDCK monolayer as an immune complex with specific
IgG, it was detected as a single, 45 kDa band, consistent rection via hFcRn as an IgG-antigen complex is deliv-
ered as a macromolecule that retains its antigenicity forwith the intact molecular weight of OVA (Figure 2E,
arrow). In either the presence of control IgG or when CD4 T cells.
applied as a specific immune complex to mock-MDCK
cells, intact OVA could not be detected (Figure 2E). To Basolateral to Apical Transport of IgG into the Lumen
exclude the possibility that the positive signal observed In Vivo Is Dependent upon hFcRn
in Figure 2E represented the transported IgG heavy We next determined whether FcRn contributes to the
chain, the same membrane was reprobed with an HRP- transport of IgG across an epithelial barrier in vivo. To
conjugated donkey anti-rabbit IgG antibody. As seen in do so, we utilized a transgenic mouse expressing both
Figure 2F, the donkey anti-rabbit antibody detected a hFcRn and h2m (hFcRnTg/h2mTg). To avoid any influ-
band consistent with the heavy chain of rabbit IgG ence of the endogenous mouse FcRn, the hFcRnTg/
(arrow) only when present as an immune complex with h2mTg mice were backcrossed on to FcRn-deficient
its specific cognate antigen either before (Figure 2F, mice. An immunoblot analysis confirmed the expression
lane 2) or after (Figure 2F, lanes 7 and 8) transport across of hFcRn and h2m in the small intestinal tissues of
the hFcRn/h2m MDCK cells. These results indicate that hFcRnTg/h2mTg/mFcRn	/	 mice but not mFcRn	/	
intact OVA/IgG immune complexes can be transported mice (Figure 4A). The expression levels of hFcRn within
across polarized epithelial cells in an apical to basolat- the intestinal epithelium of hFcRnTg/h2mTg/mFcRn	/	
eral direction via binding to hFcRn. mice were similar to those of native human intestinal
epithelial cells consistent with the fact that hFcRn in the
transgenic mice is under the control of the endogenousAntigen/IgG Complexes Transported by hFcRn
Stimulate CD4 T Cells human promoter (Figure 4B). Immunohistochemical
analysis further confirmed that hFcRn expression wasWe next determined whether the OVA transported as
an immune complex with IgG by an FcRn-mediated detectable in the epithelium of the small (data not shown)
and large intestine (Figure 4C) in the hFcRnTg/h2mTg/pathway has preserved its antigenic activity as defined
by the ability to drive MHC-restricted antigen presenta- mFcRn	/	 mice but not mFcRn	/	 mice. The detection
of hFcRn expression in the epithelium of the adult trans-tion to antigen-specific CD4 T cells. To test the effi-
ciency of an in vitro assay, naive CD4 T cells from genic mice is consistent with the fact that, in contrast to
rodents, FcRn continues to be expressed at significantDO11.10 mice with antigen-presenting cells (APCs) were
cocultured with different concentrations of antigen or levels by the intestinal epithelium of adult humans (Dick-
inson et al., 1999; Israel et al., 1997; Zhu et al., 2001).antigen/IgG complexes (Figure 3A). The expression of
CD69 was examined following 60 hr of incubation, since Moreover, as modeled by in vitro cell lines, expression
of hFcRn is associated with the bidirectional transportpreliminary studies that examined the time course of
CD69 expression revealed a progressive increase of of IgG. This latter point predicts that expression of FcRn
may account, at least in part, for the presence of IgG inCD69 expression for up to 72 hr after incubation (data
not shown). OVA as an immune complex with specific mucosal luminal surfaces in vivo.
Therefore, to examine whether hIgG transport in theIgG upregulated CD69 expression on the OVA-specific
CD4 T cells at significantly lower doses than either basolateral to apical direction is hFcRn dependent,
EPO-hIgG-Fc and the EPO-hIgG-Fc/IHH mutant, whichOVA alone or OVA/control IgG. These studies indicate
this assay has a sensitivity to detect 10 ng/mL or more is unable to bind hFcRn (Spiekermann et al., 2002), were
used. IgG binding assays showed that EPO-hIgG-Fcof OVA/anti-OVA IgG complexes.
To examine whether the OVA transported could be could bind to hFcRn in contrast to the EPO-hIgG-Fc/
IHH mutant, which could not (Figure 4D). Therefore,presented to T cells, MDCK cells were exposed apically
to either B-OVA alone, B-OVA/anti-OVA IgG, or B-OVA/ hIgG, EPO-hIgG-Fc, or the EPO-hIgG-Fc/IHH mutant
were injected intraperitoneally, and the quantities of IgGcontrol IgG and the basolateral reservoir sampled after
incubation. After standardizing the quantities of B-OVA secreted into the feces compared. EPO-hIgG-Fc could
be detected at significantly higher levels in the hFcRnTg/transported as defined by ELISA, 1.0 g/ml of B-OVA
from each collected supernatant was cultured for 24 hr h2mTg/mFcRn	/	 mice in comparison to the levels of
the EPO-hIgG-Fc/IHH mutant injected into the samewith naive CD4 T cells from DO11.10 mice and APCs
and the levels of IL-2 assessed as a measure of T cell mice (Figure 4E). These observations confirm the fidelity
of the hFcRn promoter in recapitulating the expressionactivation. When cells were pulsed with medium from
the hFcRn/h2m-MDCK cells incubated with OVA/anti- of hFcRn within the adult intestinal epithelium and the
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Figure 3. Transported Antigen/IgG Complexes Effectively Stimulate Antigen-Specific CD4 T Cells
(A) Naive CD4 T cells from DO11.10 mice and APCs were cultured with different doses of either OVA, OVA/control IgG, or OVA/anti-OVA
IgG. After 60 hr incubation, cells were collected and the surface expression of CD69 determined after gating with a DO11.10Tg-TcR-specific
antibody (KJ1-26) and anti-mouse CD4 antibody as determined by flow cytometry. Cytokine production by OVA-specific CD4 T cells (B–D).
The medium from the basolateral reservoir of a transwell system in which mock-MDCK cells (open bars) and hFcRn/h2m-MDCK cells (closed
bars) were incubated apically with B-OVA applied either alone or with anti-OVA IgG or control IgG were normalized to a B-OVA content of
1.0 g/ml by ELISA and cultured with naive CD4 T cells from DO11.10 mice and APCs. The culture supernatant was subjected to ELISA to
detect of IL-2 (B), IFN- (C), or IL-10 (D). The bars represent the mean  SD (**p  0.01) (n 
 3).
utility of this mouse/human chimera in examining the Intestinal Lumen-Derived Antigen/Antibody
Complexes Can Be Transported into the Laminain vivo function of hFcRn (Roopenian et al., 2003). More-
Propria by hFcRn In Vivo and Can Be Takenover, these studies show that hFcRn mediates the spe-
up by CD11c Cellscific transport of IgG from tissue spaces into luminal
To examine whether hFcRn can transport OVA/IgG im-secretions of the intestine.
mune complexes from the intestinal lumen into the lam-
ina propria across intestinal epithelial cells in vivo, FITC-
conjugated OVA as an immune complex with anti-OVAFormation of Antigen/IgG Complexes in the Lumen
IgG was administered intragastrically into mice. Oneas a Consequence of IgG Secretion
hour after administration, positive signals indicative ofTo examine whether secreted IgG could form complexes
the presence of FITC were detected in the epitheliumwith antigen in the lumen, either anti-OVA IgG or control
of the small intestine in hFcRnTg/h2mTg/mFcRn	/	IgG were injected i.v. into hFcRnTg/h2mTg/mFcRn	/	
(Figure 5B, arrow) but not mFcRn	/	 mice (Figure 5A).mice; a quantity of IgG was injected, which achieved
By 2 hr after administration of FITC-OVA with anti-OVAphysiological levels of antibody in the serum (0.59 
IgG to hFcRnTg/h2mTg/mFcRn	/	 mice, positive sig-0.06 versus 0.61 0.05 mg/ml, respectively) based upon
nals could be detected in cells within the lamina propriaprevious studies on the normal levels of IgG in the serum
(Figure 5D). As a control, FITC-OVA with control IgGof wild-type mice (Telleman and Junghans, 2000). Six
was administered intragastrically into hFcRn/h2mTg/
hours after the i.v. injection, B-OVA was administered
mFcRn	/	 mice. Positive signals for FITC could not be
orally. The concentrations of rabbit IgG and immune detected in either the epithelium or lamina propria of
complexes retained in the small intestinal fluid were the small intestine at 2 hr after administration in this
determined 30 min after the oral administration of anti- circumstance (Figure 5C). These data indicate that
gen by ELISA. Although no significant differences could hFcRn can direct the transport of antibody/antigen com-
be detected in the concentrations of anti-OVA IgG and plexes across the epithelium of the small intestine and
control IgG in the small intestinal fluid of the hFcRnTg/ suggest that the transported complexes can be subse-
h2mTg/mFcRn	/	 mice (Figure 4F), only in the pres- quently taken up by cells that are present within the
ence of both specific antigen and anti-OVA IgG were lamina propria.
immune complexes detected within the small intestinal We next examined whether the cells capturing the
fluid (Figure 4G). These results indicate that IgG, which FITC-OVA within the lamina propria of the small intestine
gains access to the intestinal lumen via FcRn-mediated were indeed DC. Therefore, 4 hr after inoculation of
transport, is capable of forming immune complexes with FITC-OVA with anti-OVA IgG or control IgG, cells were
obtained from the MLN and liver and examined. OVAthe cognate antigen of the secreted IgG.
Transcytosis of IgG/Antigen Complexes by FcRn
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Figure 4. Analysis of hFcRn and h2m in hFcRn/h2m Transgenic Mice on an mFcRn	/	 Background
(A) The lysates from hFcRn/h2m-MDCK and mock-MDCK cell lines and the small intestine of 8-week-old hFcRnTg/h2mTg/mFcRn	/	 and
mFcRn	/	 mice were subjected to immunolot using anti-human FcRn-CT or anti-h2m antibodies.
(B) The lysates from human small intestinal epithelial cells and the small intestine of hFcRnTg/h2mTg/mFcRn	/	 and mFcRn	/	 mice were
subjected to immunoblot using anti-human FcRn-CT antibody.
(C) Immunohistochemical analysis of hFcRn expression in the large intestine of 8-week-old hFcRnTg/h2mTg/mFcRn	/	 mice and mFcRn	/	
mice. hFcRn expression was detected within the entire epithelium of the large intestine (arrow) and lamina propria cells (arrowhead) in hFcRnTg/
h2mTg/mFcRn	/	 mice but not mFcRn	/	 mice.
(D) Specific binding of EPO-hIgG-Fc to hFcRn but not EPO-hIgG-Fc/IHH mutant. Confluent monolayers of MDCK cells transfected as indicated
were lysed in CHAPS lysis buffer (pH 6.0 or 8.0) and each lysate preincubated with 200 g of hIgG, mouse IgG1, or 100 g of EPO-hIgG-Fc
or EPO-hIgG-Fc/IHH mutant for 4 hr prior to the addition of protein G-Sepharose. Bound proteins were analyzed by SDS-PAGE under
nonreducing conditions and immunoblotting for the HA tag. Samples are as follows: lanes 1, 2, 5, 6, 9, 10, 13, and 14, mock-MDCK; lanes 3,
4, 7, 8, 11, 12, 15, and 16, hFcRn/h2m-MDCK. The images are the result of one representative experiment (n 
 2). The molecular mass in
kilodaltons is indicated on the left of each gel.
(E) Intestinal secretory human IgG-Fc concentration by ELISA. Human IgG (3 mg/mouse, circle), EPO-hIgG-Fc (1.5 mg/mouse, square), or
EPO-hIgG-Fc/IHH mutant (1.5 mg/mouse, triangle) were injected i.p. into groups of five 8-week-old hFcRnTg/h2mTg/mFcRn	/	 (closed
marks) or mFcRn	/	 mice (open marks), and the concentration of the retained human IgG-Fc tracer from serially sampled feces was determined
by ELISA. Data are shown as the mean  SD. The asterisk indicates significance for EPO-hIgG-Fc into hFcRnTg/h2mTg/mFcRn	/	 versus
EPO-hIgG-Fc/IHH mutant into hFcRnTg/h2mTg/mFcRn	/	 (* p  0.05).
(F and G) The concentrations of intestinal secretory rabbit IgG alone and as an immune complex with OVA by ELISA. Rabbit control IgG (3
mg/mouse) or anti-OVA IgG (3 mg/mouse) were injected i.v. into groups of four either hFcRnTg/h2mTg/mFcRn	/	 or mFcRn	/	 mice, and,
6 hr after the i.v. injection, B-OVA (1 mg/mouse) was administered orally. The concentrations of the rabbit IgG (F) and IgG-OVA immune
complexes (G) in the fluid of the small intestine 30 min after the oral administration was determined by ELISA. Data represents a mean  SD
(**p  0.01).
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Figure 5. Antigen/IgG Complexes Are Trans-
ported across Intestinal Epithelial Cells via
hFcRn In Vivo
FITC-OVA/anti-OVA IgG (A, B, and D) or FITC-
OVA/control IgG (C) was administered in-
tragastrically into mFcRn	/	 mice (A) or
hFcRnTg/h2mTg/mFcRn	/	 mice (B–D). Tis-
sue from the mid-small intestine was col-
lected 1 hr (A and B) and 2 hr (C and D) after
inoculation and examined by fluorescence
microscopy. (A and B) Transverse section of
small intestine. (C and D) Horizontal sections
of small intestine. Arrow in (B), intestinal epi-
thelial cells transporting FITC-OVA with rabbit
anti-OVA IgG; arrowhead in (D), FITC-positive
lamina propria cells. L, lumen; LP, lamina pro-
pria. (A–D) The magnification of images
shown is 200. Presence of FITC signals in
CD11c cells of liver 4 hr after the OVA/IgG
complex administration (E). FITC-OVA with
either control IgG or anti-OVA IgG were ad-
ministered intragastrically into mFcRn	/	
mice or hFcRnTg/h2mTg/mFcRn	/	 mice.
The cellular populations from liver were iso-
lated 4 hr after inoculation, stained with PE
conjugated anti-CD11c and 7-AAD to exclude
the dead cells, and then examined by flow
cytometry. Data are representative of four
mice analyzed in each group. (F and G) Anti-
gen-specific activation of OVA-specific CD4
T cells by antigen-bearing cells. The CD11c
cells purified from the MLN of hFcRnTg/
h2mTg/mFcRn	/	 (BALB/c) and mFcRn	/	
(BALB/c) mice were prepared 4 hr after inocu-
lation of FITC-OVA plus either anti-OVA IgG
or control IgG OVA and cultured with naive
CD4 T cells from DO11.10 mice for 60 hr.
The culture supernatants were assessed for
IFN- (F) and IL-10 (G) production by ELISA.
The mean  SD was shown for each group
(n 
 4) (**p  0.01).
uptake into antigen-presenting cells in MLN was evident Antigen Presentation by CD11c Cells to CD4 T Cells
after the Transport of OVA/IgG Complexes In Vivoby the increased mean fluorescence intensity (MFI) in
the CD11c population within MLN (OVA/control IgG, To determine whether the CD11c/FITC cells present
within the MLN can present OVA to CD4 T cells,34.0  0.9 versus OVA/anti-OVA, 43.2  1.4, p  0.01)
obtained from hFcRnTg/h2mTg/mFcRn	/	 mice. In CD11c cells purified from MLN after inoculation were
cultured with naive OVA-specific CD4 T cells. Thecomparison, the MFI in CD11c cells from MLN of
FcRn	/	 mice that received anti-OVA IgG was not signifi- CD11c cells purified from the MLN of the hFcRnTg/
h2mTg/mFcRn	/	mice that were inoculated with FITC-cantly different from that observed in the CD11c cells
from FcRn	/	 mice that received control IgG (OVA/con- OVA/anti-OVA IgG but not control IgG-stimulated IFN-
(Figure 5F) and IL-10 production (Figure 5G). However,trol IgG, 33.6  1.8 versus OVA/anti-OVA, 36.1  1.8).
In the liver, in contrast to the MLN, a discrete population CD11c cells from MLN of mFcRn	/	 mice failed to stim-
ulate OVA-specific T cells under either condition (Fig-of CD11c cells could be detected in the hFcRnTg/
h2mTg/mFcRn	/	 mice that contained high quanti- ures 5F and 5G). These findings indicate that after trans-
port of specific OVA-IgG complexes from the intestinalties of the FITC signal (Figure 5E). Such a population of
cells was not evident in the CD11c cells in liver from lumen into the lamina propria by FcRn-expressing epi-
thelial cells, CD11c cells, which have captured antigeneither FcRn	/	 mice under any conditions examined or
hFcRnTg/h2mTg/mFcRn	/	 mice that received control and are capable of presenting the transported antigen
to CD4 T cells, can be detected within the MLN.IgG (Figure 5E).
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Figure 6. Oral OVA Administration Activates
CD4DO11.10 T Cells in the MLN of
hFcRnTg/h2mTg/mFcRn	/	 that Were In-
jected with Anti-OVA IgG
hFcRnTg/h2mTg/mFcRn	/	 (BALB/c) and
mFcRn	/	 (BALB/c) mice that were adop-
tively transferred with CFSE-labeled CD4
DO11.10 T cells for the detection of cell divi-
sion or nonlabeled CD4 DO11.10 T cells for
the examination of CD69 expression were in-
jected i.v. with 3 mg of either anti-OVA IgG
or control IgG and fed OVA (0.5 mg/mouse).
Forty-eight hours later, mononuclear cells
from MLN were analyzed for the CFSE inten-
sity and CD69 expression of the CD4
DO11.10 T cells using flow cytometry. Data
are representative of four mice analyzed in
each group.
Detection of In Vivo Expansion of CD4 T Cells the mucosal surface of normal mouse lung from the
lumen to the serum (Spiekermann et al., 2002). Basedin Regional Lymphoid Tissues of Intestine
upon these studies, we examined and detected hFcRnafter Antigenic Luminal Challenge
expression in the nasal (Figure 7A) and respiratory (databy Adoptive Transfer System
not shown) epithelium of the hFcRnTg/h2mTg/We next established a model system that would reflect
mFcRn	/	but not mFcRn	/	mice by RT-PCR. To assessthe native in vivo context. To confirm the relevance of
whether IgG transported in a basolateral to apical direc-these observations, we sought to determine whether
tion could retrieve antigens from the lumen into the sub-antibody at physiological concentrations in the serum
mucosa of the respiratory system as an immune com-could retrieve antigens from the lumen for the activation
plex in vivo, B-OVA was administered by the nasal routeof T cells in the presence of hFcRn. To do so, hFcRnTg/
to mice that had been injected i.v. with either rabbit anti-h2mTg/mFcRn	/	 BALB/c mice which received CFSE-
OVA IgG or control IgG. Only in the presence of bothlabeled DO11.10 T cells by adoptive transfer were in-
specific circulating anti-OVA IgG and luminal B-OVAjected i.v. with anti-OVA IgG or control IgG followed by
could transport of B-OVA be detected in hFcRnTg/a single OVA feeding (0.5 mg/mouse). The administration
h2mTg/mFcRn	/	but not mFcRn	/	mice as a complexof OVA caused an expansion of CD4 DO11.10 T cells
with IgG (Figures 7C and 7D). In addition, administrationas defined by the detection of multiple cell divisions in
of OVA (0.5 g/mouse) through the nasal route led to aCFSE-loaded transgenic T cells and an upregulation of
significant expansion of CFSE-labeled CD4 DO11.10CD69 expression on CD4DO11.10 nonlabeled T cells in
T cells in the nasal-associated lymphoid tissue (NALT)the MLN (Figure 6D) of the hFcRnTg/h2mTg/mFcRn	/	
in hFcRnTg/h2m/mFcRn	/	Tg mice injected i.v. withmice that received anti-OVA IgG intravenously. No sig-
anti-OVA IgG (Figure 7F). No such expansion of CSFE-nificant expansion or upregulation of CD69 expression
labeled DO11.10 T cells was observed in hFcRnTg/could be detected in either the MLN of hFcRnTg/
h2mTg/mFcRn	/	 mice that received control IgG i.v.h2mTg/mFcRn	/	 mice that received control IgG (Fig-
(Figure 7E) and mFcRn	/	 mice injected with anti-OVAure 6C) or mFcRn	/	 mice that received anti-OVA IgG
IgG (data not shown). These results indicate that the(Figure 6B).
observed transport of immune complexes across an
intact epithelial barrier is likely to be physiologic given
Accumulation of CD4 T Cells in Regional Lymphoid the ability of hFcRn to mediate the retrieval of free anti-
Tissues of the Airway after Antigenic Luminal gen from the lumen of multiple FcRn-bearing mucosal
Challenge in the Context of Circulating tissues when antigen-specific IgG is present in vivo.
Antigen-Specific IgG
To determine whether the results observed could be Discussion
extended to other FcRn-bearing mucosal surfaces, we
performed the following studies. We have previously The recent recognition that FcRn expression continues
within several mucosal epithelial surfaces into adult lifedemonstrated transport of the Fc domain of IgG across
Immunity
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Figure 7. Detection of Physiologic Expansion of OVA-Specific CD4 T Cells in the Regional Lymphoid Tissues of the Upper Airway
(A) PCR amplification of hFcRn mRNA. Total RNA (20 ng) from nasal tissue of hFcRnTg/h2mTg/mFcRn	/	 mice and mFcRn	/	 mice was
amplified by RT-PCR. The specific RT-PCR products representing hFcRn (135 bp) and -actin (540 bp) are shown.
(B–D) Efficient transcytosis of antigen from nasal route into sera of hFcRnTg/h2mTg/mFcRn	/	 mice that were injected i.v. with antigen-
specific IgG. hFcRnTg/h2mTg/mFcRn	/	 or mFcRn	/	 mice were injected i.v. with anti-OVA IgG (3 mg/mouse) or control IgG and administered
B-OVA (1 mg/mouse) through the nasal route 2 hr after the i.v. injection. Three hours later, the sera was collected and subjected to ELISA to
measure the concentrations of rabbit IgG (B), B-OVA (C), or B-OVA/IgG immune complex (D). The bars represent the mean  SD (**p  0.01).
(E and F) Nasal OVA administration activates CD4 DO11.10 T cells in the NALT of hFcRnTg/h2mTg/mFcRn	/	 that were injected with anti-
OVA IgG. hFcRnTg/h2mTg/mFcRn	/	 (BALB/c) mice that were adoptively transferred with CFSE-labeled CD4 DO11.10 T cells were injected
i.v. with 3 mg of either anti-OVA IgG (F) or control IgG (F) and administered OVA (0.5 g/mouse). Forty-eight hours later, mononuclear cells
from NALT were analyzed for the CFSE intensity of the CD4 DO11.10 T cells using flow cytometry. Data are representative of four mice
analyzed in each group.
at a time when passive acquisition of IgG-mediated im- epithelium by utilizing genetically engineered mice to
study the in vivo function of hFcRn in the absence of themunity is nonessential and that, based upon in vitro
cellular models, FcRn expression in epithelial cells is mFcRn homolog. In this study, we have utilized mouse/
human chimera mice in which hFcRn, driven by its en-linked to a cell biologic pathway characterized by the
bidirectional transport of IgG (Claypool et al., 2002; Dick- dogenous promoter, and h2m are expressed in the
absence of endogenous mouse FcRn expression. Weinson et al., 1999; McCarthy et al., 2000; Praetor et al.,
1999), the notion has been raised that the in vivo function demonstrate here that hFcRn can transport not only IgG
but also intestinal luminal antigens as a complex withof FcRn in this context is unique. In contrast to the
mouse, which significantly downregulates FcRn expres- IgG across epithelial barriers into the lamina propria.
This conclusion is further supported by our in vitro stud-sion in the intestinal epithelium at the time of weaning,
adult humans continue to express significant levels of ies which demonstrate that OVA in a complex with a
rabbit IgG specific for OVA but not control IgG is trans-FcRn in the epithelium (Dickinson et al., 1999; Israel et
al., 1997; Zhu et al., 2001). Therefore, in this report, we ported in the apical to basolateral direction across
MDCK cells transfected with hFcRn and h2m but notmodeled adult human expression of FcRn in intestinal
Transcytosis of IgG/Antigen Complexes by FcRn
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control vectors. The fact that IgG can be transported into tion, our group has reported that bafilomycin A, which
similarly neutralizes the acididity of the endosomal com-the lumen from the lamina propria in an FcRn-dependent
pathway and that IgG applied to the basolateral surface partment, abrogates transport of IgG across the polar-
ized human intestinal cell line, T84 (Dickinson et al.,of a model polarized epithelial cell monolayer and to the
serum of hFcRnTg/h2mTg/mFcRn	/	 mice in vivo can 1999). Furthermore, it is likely that the pH of the total
fluid within the lumen of the intestine is not the importantretrieve antigen from the apical luminal milieu for trans-
port back to the basolateral surface as an immune com- driving force for transcytosis of IgG and IgG/antigen
complexes. Although fluid phase endocytosis and bind-plex suggests that this transcytotic pathway associated
with hFcRn is physiologic. The fact that we observed ing in acidic endosomes may be expected to be the
primary mode of ligand binding through the basolateralthe transport of IgG in the basolateral to apical direction,
as revealed by the presence of IgG in intestinal secre- surface, the presence of an acidic microenvironment
immediately adjacent to the apical plasma membranetions in mice expressing the human transgene, further
suggests that hFcRn is responsible, to a significant ex- exists at all mucosal surfaces that express the sodium-
hydrogen exchanger NHE3 (Tse et al., 1993). In the intes-tent, for the presence of IgG within luminal secretions.
In the current report, we have also utilized a trans- tine, the acidic microenvironment established by NHE3
at the brush border is used to drive both peptide andfected model system utilizing MDCK cells. A detailed
characterization of the cell biology of human FcRn as Fe2 absorption via proton-coupled transporters and is
predicted to drive IgG binding to hFcRn for basolaterallyexpressed in the h2mMDCK cells used here has been
recently reported (Claypool et al., 2004). The fraction of directed transcytosis from the apical cell surface as has
been shown for transport of peptides and Fe2 as noted.hFcRn on the plasma membrane (most FcRn resides
within the endosomal compartment; Berryman and Ro- As such, we suggest that hFcRn is involved in the entire
process of IgG transport into the lumen, antigen/IgGdewald, 1995) is almost exclusively localized to the ba-
solateral plasma membrane in these cells. However, we complex uptake from the lumen, and transcytosis from
the lumen to basolateral surface.have observed that hFcRn traffics transiently to the api-
cal plasma membrane (Claypool et al., 2004). Impor- To show that the function of FcRn is physiologic in vivo
in our system, we injected rabbit IgG to achieve a totaltantly, the steady-state localization of hFcRn in the
MDCK model is the same as is detected in two different concentration of 0.5–0.6 mg/ml. Since the rabbit IgG
utilized in the experiments described in the current re-polarized human intestinal epithelial cell lines, T84 and
Caco-2, which express hFcRn endogenously. The mem- port was polyclonal, we can further predict that approxi-
mately 10%–20% of the antibody is specific for OVA,brane distribution of the hFcRn expressed in the trans-
genic mice is currently unknown. By fluorescence mi- indicating that the specific antibody levels in the experi-
mental model used may be estimated to be in the rangecroscopy, the bulk of the signal detected occurs in an
endosomal compartment located in the subapical region of 0.05–0.12 mg/ml. Since the serum levels of total en-
dogenous IgG in normal 8- to 12-week-old mice is 3.0–of the epithelial cell. This is entirely consistent with the
observed distribution of hFcRn in human intestinal epi- 8.0 mg/ml (Telleman and Junghans, 2000) and the total
endogenous IgG levels in mFcRn	/	 and hFcRnTg/thelial cells in vivo and in vitro (Dickinson et al., 1999).
We have previously determined that while the pres- h2mTg/mFcRn	/	 mice are lower than wild-type mice,
varying between 0.3 to 0.8 mg/ml due to the loss ofence of an experimentally established pH gradient is
required for apical to basolateral transcytosis in the FcRn-mediated protection of mouse IgG from catabo-
lism (Roopenian et al., 2003), we can estimate that theMDCK clones utilized in these studies, significant baso-
lateral to apical transport of IgG relative to mock-trans- specific rabbit anti-OVA IgG levels examined represent
1.25%–3.3% of the circulating antibody pool in normalfected MDCK cells can be detected in the absence of
a pH gradient, albeit to a lesser extent than when a pH mice and 12.5%–33.3% in mFcRn	/	 and hFcTnTg/
h2mTg/mFcRn	/	mice. This should be contrasted withgradient is present (Claypool et al., 2004). As such, we
buffered the apical chamber to pH 6.0 to enhance FcRn- the serum levels of total IgG in a hyperimmunized state,
a situation in which the concentration of antibody aremediated transcytosis as previously described by us
and others (Claypool et al., 2002, 2004; McCarthy et al., at least 50–100 times greater than the levels examined
here (Christianson et al., 1997). As a corollary, the dose2000; Wu and Simister, 2001). We believe that this is
reasonable model for FcRn function for the following of antigen administrated in the GALT experiments (0.5
mg/mouse) and in the NALT experiments (0.5g/mouse)reasons. The pH in the duodenum to jejunum of neonatal
rats is 6–6.5 (Rodewald, 1976). Therefore, maternal IgG would be equivalent to 1.5 g and 1.5 mg of protein to a
60 kg human, respectively. Therefore, the quantities ofin milk can bind FcRn on the luminal surface of epithelial
cells in the neonatal rat model. However, IgG may also circulating IgG and mucosally administered antigen that
we investigated can be considered to be within the phys-bind its receptor following uptake in the acidic endoso-
mal system (Benlounes et al., 1995). This is the probable iologic range, making it likely that FcRn-mediated up-
take of antigens is a normally operative mechanism ofroute of IgG entry in cells bathed in a neutral environ-
ment, including the fetal yolk sac of rodents (Roberts et mucosal antigen handling.
Perhaps most importantly, the FcRn-mediated trans-al., 1990) and the human placental syncytiotrophoblast
(Leach et al., 1996). In fact, monensin which breaks down port of antigen/IgG complexes from the intestinal lumen
is associated with antigen capture by antigen-present-Na and Hgradients in endosomal and lysosomal com-
partments, raising the pH of endocytic vesicles from 5.5 ing cells within the intestinal lamina propria. M cells, a
specialized epithelial cell type which is present in theto greater than 7, almost completely inhibited trans-
cytosis of Fc across FcRn transfected rat inner medul- follicle-associated epithelium, have been previously
considered as the major “professional” antigen sam-lary collecting duct cells (McCarthy et al., 2000). In addi-
Immunity
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pling cell type that is capable of delivering luminal anti- lymphoid tissues thus allowing for interactions with
gens into the lamina propria (Iwasaki and Kelsall, 1999). CD4 T cells. Such a mechanism defines a major path-
In addition, intestinal DC have been demonstrated to way of antigen entry into mucosal tissues.
directly capture antigens present in the intestinal lumen
Experimental Proceduresby opening the tight junctions between epithelial cells
and sending dendrites into the lumen for antigen capture
Cells and In Vitro Transcytosis Assaysand retrieval (Hayday and Viney, 2000; Rescigno et al.,
The MDCK cells transfected with full length HA-tagged hFcRn and
2001). Our present findings demonstrate an additional h2m (hFcRn/2m-MDCK) and mock-MDCK have been established,
pathway for intestinal antigen sampling that is likely and transcytosis assays were carried out as previously described
mediated by all FcRn-expressing epithelial cells in adult (Claypool et al., 2002).
life given our ability to detect FcRn-mediated transport
Determination of IgGs and Antigen/IgG Complexesof immune complexes in both the GALT and the NALT.
by ELISA and ImmunoblotAs a striking difference from other sampling pathways,
Mouse anti-hIgG (Zymed) and mouse anti-hIgG-HRP (Zymed) forFcRn delivers intestinal antigens as a complex with IgG.
the hIgG, mouse anti-rabbit IgG (Sigma) and goat anti-rabbit IgG-Moreover, as shown here, lamina propria cells efficiently
HRP (Piece) for the rabbit IgG, OVA (Sigma) and donkey anti-rabbit
capture these IgG/antigen complexes consistent with IgG-HRP for rabbit anti-OVA IgG, avidin (Piece), rabbit anti-OVA IgG
recent studies, which have demonstrated that immune and donkey anti-rabbit IgG-HRP for the B-OVA, and avidin and
complexes can be captured by DC (Mellman and donkey anti-rabbit IgG-HRP for B-OVA/anti-OVA IgG complex were
used, respectively. For the detection of B-OVA/anti-OVA IgG com-Steinman, 2001).
plex by immunoblot, mouse anti-OVA IgG (clone OVA-14, Sigma)After capturing antigens in the intestinal lamina pro-
followed by goat anti-mouse IgG1-HRP was used.pria, DC have been demonstrated to rapidly migrate into
other tissues, such as MLN (Huang et al., 2000). Indeed,
IgG Binding Assay
our present studies show that the lamina propria cells IgG binding assays were performed as previously described (Clay-
that captured OVA as a complex with specific IgG move pool et al., 2002). Human IgG, rabbit control IgG, rabbit anti-OVA
into the MLN as well as the liver within 4 hr of antigen IgG, mouse IgG1, erythropoietin conjugated hIgG-Fc(EPO-hIgG-Fc),
or EPO-hIgG-Fc/IHH mutant containing three point mutations thatinstillation in the intestinal lumen. In addition, our obser-
abrogate Fc binding to FcRn (Spiekermann et al., 2002) were utilized.vation that a FITC signal, indicative of the incorporation
of OVA/IgG complexes, can be detected in a significant
Immunocytochemistry and Confocal Microcsopyproportion of CD11c cells in these tissues suggests
Immunocytochemistry of MDCK cells grown on Transwell was per-that the process described here is a major means by
formed as described (Claypool et al., 2004). Goat IgG was detected
which antigen may be captured by a host that has pre- with rabbit anti-goat IgG-HRP, followed by Tyramide Signal Amplifi-
viously raised an IgG immune response to a foreign cation Alexa488 kit (Molecular Probe), and ZO-1 was revealed with
antigen. Furthermore, the CD11c cells in MLN that have mouse anti-ZO-1 (Zymed), followed by goat anti-mouse IgG-Alexa568
(Molecular Probe). The images were gathered using a MRC1024captured OVA as a complex with IgG efficiently present
laser scanning confocal system (Bio-Rad Laboratories).the antigen to OVA-specific CD4T cells. Recent studies
have suggested that the manner in which antigen is
Preparation of Cell Suspensions from Spleen, MLN, and Livertaken up by a DC confers distinct functions on the DC
T cells from spleen, MLN, and NALT were prepared as previously
(Mellman and Steinman, 2001). Interestingly, FcRIIB- described (Fukuyama et al., 2002). Dendritic cells were prepared
mediated capture of immune complexes are involved in from MLN and liver using a digestion buffer as described previously
the generation of dendritic cell-mediated immune toler- with a modification (Watanabe et al., 2002). In short, MLN and liver
were digested with collagenase (1 mg/ml) and DNase I (15 g/ml)ance (Kalergis and Ravetch, 2002). In addition, immuno-
for 30 min at 37C and then passed through a cell strainer. Sampleglobulins have been proposed to suppress intestinal
was centrifuged and the pellet resuspended in 4 ml 40% Percoll ininflammation by facilitating phagocytosis of pathogenic
PBS, underlaid with 2 ml of 60% Percoll in PBS, and centrifuged atantigens (Mizoguchi et al., 1997a) and IgG in the lumen
2200 rpm for 20 min. Cells were carefully collected from the interface,
of lung has been suggested to reduce allergen-induced washed with PBS, and utilized.
asthma (Sehra et al., 2003). In our study, significant IL-10
production by CD4 T cells was observed when stimu- Antigen-Specific Stimulation by Antigen/IgG Complex
lated by antigen-presenting cells isolated from the MLN Transported across MDCK Cells
Naive splenic CD4 T cells (1  106/ml) purified from DO11.10 miceand liver that had received the OVA antigen after trans-
by a purification column (R & D Systems) and mitomycin C treatedcytosis via hFcRn. Therefore, it is possible that the sam-
BALB/c splenocytes (1x107/ml) as antigen-presenting cells (APCs)pling of intestinal luminal antigens by an FcRn-mediated
were cultured with different doses of either OVA, OVA/control IgG,process contributes to unique functions of mucosal ef-
or OVA/anti-OVA IgG (the ratio of OVA:IgG is 1:3 weight/volume). For
fector and/or regulatory pathways involved in the main- cytokine assays, the same quantity of B-OVA from the basolateral
tenance of mucosal tolerance characteristic of this com- reservoir was used, and cells were cultured for 24 hr (IL-2) or for 60
partment or the development of intestinal inflammation hr (IFN- and IL-10). Detection levels of the cytokine ELISAs are
16.5 pg/ml (IFN-) and 7.8 pg/ml (IL-10).as might occur if the transported antigen has adjuvant
qualities. Further studies will be needed to clarify these
Multicolor Flow Cytometric Analysisimportant issues.
PE-labeled anti-CD11c (clone HL3), FITC-labeled CD69 (cloneIn this study, we provide an insight into the role of
H1.2F3), PE-labeled anti-mouse DO11.10 T cell receptor (clone KJ1-hFcRn in the transport of luminal antigens as a complex
26; CALTAG Laboratories), and PerCP-Cy5.5-labeled CD4 (clone
with antigen-specific IgG by absorptive intestinal epithe- RM4-5) were used in this study. For the DC staining, Via-Probe
lial cells and epithelial cells of the upper airway that (7-amino-actinomycin D; 7-AAD; PharMingen) was added to gate
express hFcRn. Antigen capture stimulates the migra- out the dead cells. The cells were analyzed using a flow cytometer
(FACSort, Becton-Dickinson).tion of CD11c dendritic cells to regional organized
Transcytosis of IgG/Antigen Complexes by FcRn
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Mice In Vivo Transport Experiment
To assess the physiological transport of antigen as an immuneFcRn-deficient mice (mFcRn	/	) and the hFcRn transgenic (Tg) mice
under the control of the human endogenous promoter were estab- complex from the lumen into the serum by FcRn in vivo, mice were
injected i.v. with either rabbit anti-OVA IgG or control IgG and admin-lished previously (Roopenian et al., 2003). The hFcRnTg mice were
crossed to h2mTg mice (Krimpenfort et al., 1987) and further istered B-OVA per the nasal route 2 hr after i.v. injection. After 3 hr,
the sera was collected and subjected to ELISA.crossed with a FcRn	/	 mouse of both C57BL/6 and BALB/c back-
grounds (hFcRnTg/2mTg/mFcRn	/	). For the OVA studies,
DO11.10 mice expressing a transgenic T cell receptor that recog- Adoptive Transfer and CFSE Labeling of CD4 DO11.10
nized a peptide fragment of OVA in the context of IAd (Murphy et T Cells and Antigenic Challenge
al., 1990) were used. All mice were housed under specific pathogen- As described previously (Yoshida et al., 2002; D’Souza and Lefran-
free conditions at the Animal Facilities of Harvard Medical School. cois, 2003), 8- to 12-week-old hFcRnTg/h2mTg/mFcRn	/	
(BALB/c) or FcRn	/	 (BALB/c) mice were reconstituted with 1  107
CFSE-labeled T cells from DO.11.10/Rag1	/	 mice. The recipientDetection of the hFcRn by Immunoblot
mice were injected i.v. with either anti-OVA IgG or control IgG 24and Immunohistochemistry
hr after transfer, followed by oral administration of 0.5 mg OVA 24The expression of hFcRn and h2m was assessed by immunoblot
hr after IgG injection. In NALT experiments, 0.5 g of OVA wereanalysis using a rabbit antibody specific for the hFcRn-CT (Claypool
administered intranasally into the recipient mice as describedet al., 2002) and a goat antibody specific for h2m (Santa Cruz),
above. The mononuclear cells were prepared from MLN or NALT 2respectively. Normal adult human small intestine was obtained from
days after the oral feeding.patients undergoing gastric bypass surgery, and epithelial cells were
nonenzymatically isolated as described (Blumberg et al., 1991) un-
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